课题基金 / 基金详情

Enediyne Antitumor Antibiotic Synthesis - Streptomycetes

Enediyne Antitumor Antibiotic Synthesis - Streptomycetes
烯二炔抗肿瘤抗生素合成 - 链霉菌
批准号:
6532903
负责人:
Ben Shen
金额:
$10.69万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2006-05-31

项目摘要

项目成果

Ben Shen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Enediyne antibiotics are the most potent, highly active antitumor agents in existence today. Neocarzinostatin (NCS) and its conjugates have shown great clinical promise in anticancer chemotherapy, and several calicheamicin-antibody and C-1027-antibody conjugates have produced outstanding results in recent clinical trials or model studies. Therefore, it is a critical research goal to develop ways to make the enediynes and their analogs for further studies. This application proposes to clone and characterize the genes for NCS production in Streptomyces carzinostaticus, complementing our on going effort for C-1027 in Streptomyces globisporus, in an attempt to synthesize novel antitumor drugs by manipulating genes governing enediyne antibiotic biosynthesis. This proposal is based on the hypothesis that the NCS chromophore is derived from three biosynthetic building blocks an enediyne core, a deoxy aminosugar, and a polyketide naphthoic acid moiety. Three corollaries of this hypothesis are (1) that the extensive knowledge of deoxysugar and polyketide biosynthesis in actinomycetes should greatly aid the effort to clone the genes for deoxy aminosugar and naphthoic acid biosynthesis from S. carzinostaticus, (2) that the structural similarity between the enediyne cores of NCS and C-1027 provides an unique opportunity to decipher the genetic and biochemical basis of enediyne core assembly, and (3) that the genetic tools and technology developed in Streptomyces species for antibiotic biosynthesis should be directly applicable to manipulating NCS and C-1027 biosynthesis genes for yield improvement and analog or novel enediyne production. The specific aims for the five-year award period are (1) to clone and sequence the entire NCS biosynthetic gene cluster from S. carzinostaticus, (2) to develop a genetic system for S. carzinostaticus to manipulate NCS biosynthesis in viva, (3) to confirm the cloned S. carzinostaticus DNA encoding NCS biosynthesis and to localize the boundaries of the NCS gene cluster by gene disruption and replacement experiments, and (4) to identify genes essential for the enediyne core biosynthesis by comparing the NCS and C-1027 biosynthetic gene clusters and to demonstrate the synthesis of an enediyne core structure by expressing the corresponding genes in a heterologous host. The outcome of these studies will reveal new insights into the biosynthesis of the enediyne family of antibiotics, shedding light on rational engineering of enediyne biosynthesis in these as well as other enediyne-producing organisms, and could realistically lead to the making of fundamentally new, clinically useful antitumor agents
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mining Actinomycetal Genomes for Natural Product Discovery and Biosynthesis
  • 批准号:
    10640298
  • 项目类别:
  • 资助金额:
    $60.33万
  • 财政年份:
    2020
  • 负责人:
    Ben Shen
  • 依托单位:
Mining Actinomycetal Genomes for Natural Product Discovery and Biosynthesis
  • 批准号:
    10292987
  • 项目类别:
  • 资助金额:
    $19.21万
  • 财政年份:
    2020
  • 负责人:
    Ben Shen
  • 依托单位:
Mining Actinomycetal Genomes for Natural Product Discovery and Biosynthesis
  • 批准号:
    10064144
  • 项目类别:
  • 资助金额:
    $79.55万
  • 财政年份:
    2020
  • 负责人:
    Ben Shen
  • 依托单位:
Genome Mining for Enediyne Natural Products from Actinomycetals
  • 批准号:
    9233171
  • 项目类别:
  • 资助金额:
    $48.0万
  • 财政年份:
    2016
  • 负责人:
    Ben Shen
  • 依托单位:
国内基金
海外基金
Streptomyces rochei D21E05 次级代谢产物分离纯化及其活性功能研究
Streptomyces rimosus M527特异性高强度合成龟裂霉素的多模块协同改造
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    马正
  • 依托单位:
深海放线菌Streptomyces sp. 11695的抗菌活性次级代谢产物基因组挖掘
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
    罗明和
  • 依托单位:
基于TAG途径解析 Streptomyces exfoliates A1013Y中蓝色素代谢调控分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    朱运平
  • 依托单位: